# Study of DCR-AUD in Healthy Volunteers

> **NCT05021640** · PHASE1 · COMPLETED · sponsor: **Dicerna Pharmaceuticals, Inc., a Novo Nordisk company** · enrollment: 36 (actual)

## Conditions studied

- Alcohol Use Disorder (AUD)

## Interventions

- **DRUG:** DCR-AUD
- **DRUG:** Placebo for DCR-AUD

## Key facts

- **NCT ID:** NCT05021640
- **Lead sponsor:** Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-21
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05021640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05021640, "Study of DCR-AUD in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05021640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*